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Introduction
Diabetes mellitus is currently one of the most important public health issues of the 21st century 
affecting an estimated 347 million people worldwide with low- and middle-income countries 
currently being home to 75% of the world’s diabetic population.1 Sub-Saharan Africa is currently 
facing an epidemic of type 2 diabetes mellitus, thought to have arisen because of rapid urbanisation, 
an increasingly ageing population and major changes in lifestyle.2,3
Purpose: The prevalence of diabetes mellitus is increasing especially in low- and middle-
income countries in which 75% of the world’s diabetic population reside. The macro- and 
microvascular complications of diabetes such as diabetic retinopathy are also set to increase in 
these populations.
The relationship between depression and glycaemic control has been established in high-
income countries, but evidence from low- and middle-income countries is scarce. This research 
aimed to determine an association between depression and glycaemic control and record the 
prevalence of diabetic retinopathy in a diabetic population in Cameroon.
Methods: Analysis of cross-sectional data from the ‘Improving access to HbA1c measurements 
in sub-Saharan Africa’ study was used. Primary data were collected from six diabetic care 
facilities in Yaoundé, Cameroon. Participants were aged ≥ 18 years with at least a 6-month 
history of diabetes. Depression was assessed using the Centre for Epidemiological Studies 
Depression Scale (CES-D). A CES-D score ≥ 16 was used to identify the presence of clinically 
significant depressive symptoms. Data on glycaemic control were measured using HbA1c 
measurements at baseline. The presence of diabetic retinopathy was established through 
ophthalmoscopy and angiography using the Early Treatment Diabetic Retinopathy Study 
classification.
Results: A total of 261 participants were included in the study, and information on depressive 
symptoms at baseline (CES-D score) were available for 240 participants. The results of the data 
analysis found that 60% of the study participants had clinically significant depressive 
symptoms (CES-D > 16). A weak non-significant positive correlation was found between 
CES-D score and HbA1c level (p = 0.46, r = 0.05) using the Pearson’s correlation co-efficient. 
Gender and attendance to a patient support group were significantly associated with the 
presence of clinically significant depressive symptoms. Poor glycaemic control (HbA1c > 7%) 
was found in 72.8% of the population. Educational level and insulin use were significantly 
associated with glycaemic control.
The prevalence of diabetic retinopathy was 27.2% (23.4% non-proliferative, 2.5% pre-
proliferative and 3.2% proliferative), and the prevalence of diabetic maculopathy was 10.0%.
Conclusion: The study found that a large proportion of diabetic patients may be experiencing 
depressive symptoms for which they are currently not receiving treatment or support. We also 
found a large proportion to have poor glycaemic control that is known to worsen the vascular 
complications of diabetes. In light of the increasing epidemic of type 2 diabetes in sub-Saharan 
Africa, it is important that the recognition of depressive symptoms becomes integrated into 
future healthcare policies in the nations of sub-Saharan Africa. This research suggests that 
individuals experiencing depressive symptoms may be more likely to engage in patient 
support groups. These groups can be beneficial in providing patients with diabetes valuable 
information, which could lead to better glycaemic control.
Association between depression, glycaemic control  
and the prevalence of diabetic retinopathy in a  
diabetic population in Cameroon
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Depression is the leading cause of disability worldwide 
and is a major contributor to the global burden of disease, 
affecting an estimated 350 million people.4 Research has 
shown depression to be associated with a high mortality in 
people with diabetes.5,6,7,8 Patients with diabetes are twice as 
likely to be depressed compared to those without diabetes.9 
Alongside this, depression can also lead to an increased risk 
of the vascular complications of diabetes such as diabetic 
retinopathy, neuropathy and cardiovascular disease.10
Diabetic retinopathy is a microvascular complication of 
diabetes and is the leading cause of blindness in people of 
working age in Europe and North America.11 In sub-Saharan 
Africa, the prevalence of retinopathy in patients with diabetes 
varies across the continent ranging from 16 in some regions 
to 55% in other regions.2 Estimates of prevalence vary 
according to duration, clinical site and glycaemic control. 
The contribution to overall blindness in sub-Saharan Africa 
is unknown, but studies suggest that the proportional 
contribution may be increasing.2 Studies to date involving 
multiethnic populations living in sub-Saharan Africa have 
found that visual loss relating to diabetic retinopathy is more 
likely in populations of African origin compared to those of 
other ethnic minorities living in sub-Saharan Africa.12
Literature on depression in people residing in low- and 
middle-income countries is limited but growing evidence 
demonstrates the negative impact of poverty and mental 
health illness on people living in these regions.13 Much of the 
research surrounding depression and type 2 diabetes that has 
been conducted in low- and middle-income countries have 
primarily been conducted in middle-income economies such 
as India, China, Mexico and Brazil.14
Over the past 50 years, there has been an increased awareness 
of depression in sub-Saharan Africa.15 Prior to this, depression 
was assumed to be non-existent in Africa, and even today, 
the prevalence may still be underestimated.16,17 However, 
information about depressive symptoms in individuals 
living with chronic illnesses in sub-Saharan Africa is still 
scarce.18 Despite this, research from low-income economies 
such as Bangladesh and Guinea suggests that anxiety and 
depressive symptoms are common in patients living with 
diabetes.19,20
The aim of this research was to analyse the association 
between depressive symptoms and glycaemic control and 
record the prevalence of diabetic retinopathy in a clinical 
sample of patients with diabetes from the ‘Improving access 
to HbA1c measurement in sub-Saharan Africa’ project.21
Materials and methods
Data were collected from a multicentre hospital cohort 
involving six diabetic care facilities in Yaoundé, Cameroon. 
This study was performed as secondary data analysis of the 
‘Improving access to HbA1c measurement in sub-Saharan 
Africa’ study.22 The empirical study was an interventional 
study aiming to improve access to HbA1c measurements in 
sub-Saharan Africa. The empirical research was conducted 
from 01 November 2008 to 30 April 2012 in Guinea and 
Cameroon involving a total of 410 diabetic adult patients 
with both type 1 and type 2 diabetes mellitus and had a 97% 
response rate.
Secondary data were analysed from a total of 261 of the 
410 participants who had HbA1c scores recorded at baseline. 
The study included participants aged 18 years and older 
who had at least a 6-month documented history of diabetes. 
Patients who had been diagnosed for less than 6 months and 
those with other acute medical or metabolic conditions were 
excluded from the study.
Primary data were collected through a semistructured 
questionnaire. The questionnaire was administered by 
either a nurse or another healthcare professional and 
contained anonymised information on HbA1c control, 
socio-demographic characteristics and diabetes-related 
characteristics and risk factors for diabetes. Data on the 
presence of diabetic retinopathy and depressive symptoms at 
baseline were also collected.
The socio-demographic data included age, gender, 
employment status, marital status and educational level. 
Educational level was divided into those who had 
achieved primary education or less (including those with no 
formal education) and those who had achieved secondary 
education and higher. Diabetes-related characteristics such 
as hypertension, obesity, insulin use and glycaemic control 
were included. Involvement in physical activity and patient 
support groups were also included. Obesity was measured 
according to the World Health Organisation classification 
for adult obesity with a body mass index (BMI) > 30 kg/m2 
used to define obesity. Information on glycaemic control was 
obtained through HbA1c measurements. This analysis used 
anonymised information about HbA1c readings taken in a 
clinic by a trained physician at baseline.
The presence of diabetic retinopathy was detected through 
the use of a clinical eye examination, fundoscopy and 
fluorescein angiography. All cases of retinopathy were 
detected by an ophthalmologist using retinal photographs. 
Diabetic retinopathy was classified as absent, non-
proliferative, pre-proliferative and proliferative according 
to the Early Treatment Diabetic Retinopathy Study 
classification.23 The presence of diabetic maculopathy was 
diagnosed through fundal examination.
Information on depressive symptoms at baseline was 
assessed through the use of the Centre for Epidemiological 
Studies Depression Scale (CES-D). The CES-D scale was 
created by Laurie Radloff in 1977 as a self-administered 
questionnaire to assess current levels of depressive symptoms 
in the general population.24 Questions for the scale are drawn 
from other inventories including the Beck Depression 
Inventory, Zung Self-Rating depression Scale and the 
Raskin Scale. However, the CES-D scale differs from previous 
depression scales because of its focus on identifying 
Page 3 of 7 Original Research
http://www.sajpsychiatry.org Open Access
depressive symptomology in the general population rather 
than diagnosing depression in a clinical setting.24
The CES-D scale was originally designed to screen for 
depressive symptomology in North American populations; 
however, it has since been used widely in a variety of sub-
Saharan nations such as Uganda, Zambia, Nigeria and 
Senegal and validated in South Africa, Zambia, Uganda and 
Nigeria.25,26,27,28,29 The 20-item questionnaire centres on the 
major clinical symptoms of depression. Answers are given 
on a score of 0–3 relating to the frequency of symptoms 
experienced during the past week. The possible scores range 
from 0 to 60 with high scores indicating more depressive 
symptoms. A recommended score of greater than 16 is 
usually recommended to suggest the presence of clinically 
meaningful depressive symptoms. In this study, individuals 
with CES-D scores > 16 were identified as having clinically 
significant depressive symptoms.
Statistical analysis
The original data were obtained within the SPSS statistics 19 
package.30 Analysis was made using the Minitab 16 and Epi 
Info™ 7 statistical software.31,32 Categorical variables were 
analysed using chi-squared test or Fisher’s exact tests if the 
expected cell counts were less than 5. Assessment for effect 
modification and confounding was conducted.
Ethical considerations
The National Ethics Committee in Cameroon approved the 
study. Participants involved in the study gave written 
informed consent to voluntarily participate in the study and 
permission to use information for the purpose of secondary 
data analysis. We certify that all applicable institutional 
and governmental regulations concerning the ethical use of 
human volunteers were followed during this research. This 
research adhered to the Declaration of Helsinki and was 
reviewed by the Institutional Review Board at Newcastle 
University.
Results
A total of 261 individuals were included in the secondary 
analysis for which HbA1c was recorded at baseline. A total of 
240 of these participants had depressive symptoms (CES-D 
scores) recorded at baseline. The general characteristics 
included in the study are presented in Table 1. Missing 
variables were noted and the categorical variables for which 
there were incomplete data sets were not included in the 
statistical analysis (see Tables 3 and 4).
The study had a female majority (56.3%) with a mean age 
was 56 years and a standard deviation (SD) of 12.21. The age 
data followed an approximately normal distribution, with an 
age range of 16–85.
Most individuals had secondary education or higher (57.1%), 
and 42.9% had primary education or less. The majority of the 
sample population were married (65.9%) and 34.1% were 
classified as single with just over half of the population 
(55.1%) identifying as either retired or unemployed.
The majority of participants (92.7%) were reported as having 
type 2 diabetes mellitus (see Table 2). Just over half of the 
study participants (57.0%) had diabetes for ≥ 5 years, 31.1% 
of the population were defined as obese and 57.0% of 
TABLE 1: Baseline demographics for diabetes-related characteristics in a sample 
population.
Characteristics (n = 261) Number (%)
Sex
 Male 114 (43.7)
 Female 147 (56.3)
Marital status
 Married 170 (65.9)
 Single 88 (34.1)
Educational level
 Primary or less 112 (42.9)
 Secondary or higher 149 (57.1)
Employment
 Employed 117 (44.9)
 Unemployed 144 (55.1)
Alcohol consumption
 Yes 62 (32.1)
 No 131(67.9)
TABLE 2: Diabetes-related categorical characteristics in the study population.
Diabetes-related characteristics (n = 261) Number (%)
Type
 1 16 (6.1)
 2 242 (92.7)
 Other 3 (1.6)
Duration
 < 5 years 110 (43.0)
 ≥ 5 years 146 (57.0)
Obesity
 Yes 79 (31.1)
 No 175 (68.9)
HbA1c (%)
 Good control (< 7%) 71 (27.2)
 Poor control (> 7%) 190 (72.8)
Hypertension
 Yes 135 (57.0)
 No 102 (43.0)
Insulin
 Yes 96 (36.8)
 No 165 (63.2)
Patient support group
 Yes 53 (20.3)
 No 208 (79.7)
Physical activity
 Yes 62 (27.7)
 No 162 (72.3)
Retinopathy
 Absent 115 (72.8)
 Non-proliferative 34 (23.4)
 Pre-proliferative 4 (2.5)
 Proliferative 5 (3.2)
Maculopathy
 Yes 13 (10.0)
 No 117 (90.0)
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participants were identified as having hypertension. Insulin 
use was reported in 36.8% of participants and 72.8% of the 
study population were identified as having poor glycaemic 
control (HbA1c level of > 7%). Attendance in a patient 
support group for people living with diabetes was reported 
in 20.3%.
Diabetic retinopathy
Information on diabetic retinopathy were available for 158 
(60.0%) of the 261 participants included in this study. Diabetic 
retinopathy was detected in approximately 25.0% of the 
subset for which data were available. The majority of cases 
were non-proliferative (21.5%) with smaller proportions at 
the pre-proliferative (2.5%) or proliferative (3.1%) stage. The 
presence of maculopathy was detected in 10.0% of the 
population (see Table 2).
Depressive symptomology
Of the 261 participants studied, CES-D scores were available 
for 92.0% (240) of the population, with data missing for 
23 people. For this reason, statistical analysis was only 
performed with baseline characteristics which had complete 
data sets for both CES-D score and HbA1c level (see Table 3).
A large proportion of participants had borderline depressive 
symptoms with CES-D scores around 15 and 16 at baseline, 
with scores ranging from 1 to 49 (out of a minimum score of 
0 and a maximum score of 60).
Statistical significance was found between reporting of 
clinically significant depressive symptoms (CES-D score > 16), 
gender and involvement in a patient support group for 
diabetes.
The mean CES-D score for men was 17, compared to mean 
CES-D score of 20 for women. More women (69.1%) reported 
significant depressive symptoms compared to men (49.0%, 
chi-squared p < 0.01). Individuals who had a primary 
education or less reported more clinically significant 
depressive symptoms (64.0%) compared to those with 
secondary education or more (57.9%, p = 0.33). Those who 
were unemployed reported more depressive symptoms 
(62.7%) compared to those who were employed (57.5%, p = 
0.42). Individuals who use insulin also reported more 
depressive symptoms (61.2%) compared to those who do not 
use insulin (60.0%, p = 0.86). Individuals involved in a patient 
support group were noted to have more clinically depressive 
symptoms (76.0%) compared to those not involved in a 
patient support group (56.3%, p < 0.01).
Individuals with poor glycaemic control, HbA1c > 7%, were 
found to have more depressive symptoms (61.4%) compared 
to those with good glycaemic control (HbA1c ≤ 7%) (57.5%). 
A weak positive correlation was found between CES-D score 
and HbA1c level at baseline, but this was found not to be 
statistically significant (r = 0.05, p = 0.46).
Glycaemic control
The majority of participants in the study (72.8%) were 
identified as having poor glycaemic control (HbA1c > 7%) 
at baseline. The median HbA1c score was slightly lower 
in women (8.0%) compared to men (9.0%). A significant 
association was found between educational level, insulin use 
and poor glycaemic control. A greater proportion of people 
with a higher educational level (12.0%) had poor glycaemic 
control compared to those with less education (chi-squared 
p = 0.04). A higher proportion (20.0%) of individuals on 
insulin had poor glycaemic control compared to those not 
using insulin (chi-squared p < 0.01). Men had worse glycaemic 
control (77.2%) compared to women (69.4%, p = 0.15). Those 
who were employed were identified as having poorer 
glycaemic control (77.8%) compared to those who were 
unemployed (68.7%, p = 0.10) and those who did not attend a 
TABLE 3: Baseline characteristics of study population analysed against Centre for Epidemiological Studies Depression Scale (CES-D) score.
Categorical grouping 
variables
CES-D score Proportion of individuals reporting depressive symptoms (CES-D > 16)
Total (N = 240) Mean (s.d.) Yes (%) No (%) 95% CI p
Sex
 Female 136 20.2 (7.7) 94 (69.1) 42 (30.9)
-0.32 to -0.07 < 0.01
 Male 104 17.1 (7.7) 51 (49.0) 53 (51.0)
Educational level
 Primary or less 100 19.7 (7.7) 64 (64.0) 36 (36.0)
-0.19 to 0.06 0.33
 Secondary or more 140 18.3 (8.0) 81 (57.9) 59 (42.1)
Employment status
 Employed 106 19.2 (8.5) 61 (57.5) 45 (42.5)
-0.07 to 0.17 0.42
 Unemployed 134 18.6 (7.3) 84 (62.7) 50 (37.3)
Insulin use
 Yes 85 20.1 (8.5) 52 (61.2) 33 (38.8)
-0.11 to 0.14 0.86
 No 155 18.2 (7.2) 93 (60.0) 62 (40.0)
Patient support group
 Yes 50 19.8 (7.5) 38 (76.0) 12 (24.0)
0.06 to 0.33 < 0.01
 No 190 18.6 (7.9) 107 (56.3) 83 (43.7)
Glycaemic control
 Poor (HbA1c > 7%) 176 19.0 (7.9) 108 (61.4) 68 (38.6)
-0.10 to 0.18 0.62
 Good (HbA1c ≤ 7%) 64 18.4 (7.6) 37 (57.5) 27 (42.4)
CI, Confidence interval; s.d., standard deviation.
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patient support group had poorer glycaemic control (73.6%), 
compared to those who did attend a patient support group 
(69.8%, p = 0.09) (see Table 4).
Discussion
The results of the secondary data analysis found that over 
60.0% of study participants reported clinically significant 
depressive symptoms (CES-D > 16) and over 70.0% of 
participants were reported as having poor glycaemic control 
at baseline. The study participants were not assessed for a 
criterion-based mood episode, but it is likely that at least 
some of these participants would be suffering from a mood 
episode.
The prevalence of depressive symptoms in this study was 
higher than that seen in diabetic patients in other low- and 
middle-income countries such as Jordan (19.7%), Thailand 
(~25%), India (16.9% – 43.4%) and Guinea (34.4%).18,33,34,35,36,37 
However, many of these studies differ in the scale and score 
used to identify depression and the presence of depressive 
symptoms.
The presence of clinically significant depressive symptoms 
was found to have a significant association with gender. 
Women reported higher levels of clinically significant 
depressive symptoms compared to men. This is similar to 
results found in other studies surrounding depression in 
patients with diabetes.35,38,39,40,41 Our analysis suggests a 
significant association between depression and having a 
lower educational level and being unemployed; however, 
this was not statistically significant as has been demonstrated 
in other research.35,42,43,44,45
Our study found a weak positive correlation between 
CES-D score and glycaemic control that was not statistically 
significant. However, research from various countries 
suggests a significant association.36,37,38,41,42,45,46 Despite much 
research, the exact direction of the relationship is as yet 
unknown.47 Some studies suggest that depression may be 
a consequence of living with diabetes mellitus because 
of factors such as the burden of chronic disease or the 
biochemical changes that occur in diabetes.48 Other studies 
have proposed that depressive symptoms may be a risk 
factor for developing diabetes mellitus because of a decline 
in health maintenance behaviours or biochemical changes 
associated with depression.49
The results of the study also found that individuals who were 
involved in a patient group had higher levels of clinically 
depressive symptoms compared to those who were not. 
These individuals were also found to have better glycaemic 
control, although this was not significant. This research 
suggests that individuals experiencing depressive symptoms 
may be more likely to engage in patient support groups. 
These groups can be beneficial in providing patients with 
valuable information, which could lead to better glycaemic 
control.
Study strengths
This study is one of the first to date to assess the relationship 
between depression and glycaemic control in Cameroon. 
Data were obtained from a diverse range of participants 
involving six diabetic care populations across Cameroon 
from the ‘Improving access to HbA1c measurement in 
sub-Saharan Africa’ study. This makes the data more 
representative of the population in Cameroon.
Limitations
A limitation to this study is that a self-report measure was 
used to assess depressive symptomology. This could explain 
the higher rates of depressive symptoms in the population as 
self-report measures often lead to higher rates of depression 
compared to methods using formal psychiatric interviews.50 
In this study, CES-D scored > 16 were used to demonstrate 
clinically significant depressive symptoms. However, some 
studies have used recommended cut-off points of 16–23 as 
having ‘distressed symptoms’ and > 23 as being ‘depressed’.25 
CES-D scores using cut-off points between 21 and 23 have 
been shown to have a sensitivity and specificity greater than 
85%.51,46
TABLE 4: Baseline characteristics of study population analysed against glycaemic control.
Categorical grouping variables Total (N = 261) Good control HbA1c ≤ 7% N (%) Poor control HbA1c > 7% N (%) 95% CI p
Sex
 Female 147 45 (30.6) 102 (69.4)
 Male 114 26 (22.8) 88 (77.2) -0.33 to 0.19 0.15
Educational level
 Primary or less 112 38 (33.9) 74 (66.1)
 Secondary or more 149 33 (22.1) 116 (77.9) < -0.01 to 0.22 0.04
Employment status
 Employed 117 26 (22.2) 91 (77.8)
 Unemployed 144 45 (31.3) 99 (68.7) -0.02 to 0.20 0.10
Insulin use
 Yes 96 14 (14.6) 82 (85.4)
 No 165 57 (34.5) 108 (65.5) 0.09 to 0.30 < 0.01
Patient support group
 Yes 53 16 (30.2) 37 (69.8)
 No 208 55 (26.4) 153 (73.6) -0.21 to 0.02 0.09
CI, Confidence interval.
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The CES-D scale has also not yet been validated for use in 
Cameroon but has been widely used and validated for 
research in patient populations in various sub-Saharan 
African nations.
Conclusion
The established increase in diabetes mellitus in low- and 
middle-income countries indicates the need for further 
research. In particular, the association between depressive 
symptoms and glycaemic control should be explored to allow 
close monitoring of HbA1c in individuals most at risk. The 
finding from this piece of research highlights the need for 
increased monitoring of HbA1c levels and detection of 
depressive symptoms, which might be consequent to a mood 
disorder. This should be achieved through appropriate and 
valid assessment by healthcare professionals, particularly in 
high-risk groups such as women, the unemployed, those 
with lower levels of education and those using insulin. It also 
suggests that patient support groups in low- and middle-
income countries could help those most at risk of depressive 
symptoms and encourage education on how to maintain 
better glycaemic control.
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